Back
C4 Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
CCCC
C4 Therapeutics, Inc.
Last Price:
$2.01
Seasonality Move:
-24.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCCC is experiencing selling pressure, which indicates risk of future bearish movement.
C4 Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.3 | Sell |
| 20-day SMA: | 2.47 | Sell |
| 50-day SMA: | 2.43 | Sell |
| 200-day SMA: | 2.08 | Sell |
| 8-day EMA: | 2.23 | Sell |
| 20-day EMA: | 2.38 | Sell |
| 50-day EMA: | 2.4 | Sell |
| 200-day EMA: | 1.58 | Buy |
C4 Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 34.58 | Sell |
| Chaikin Money Flow: | -1068867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.27 - 2.67) | Sell |
| Bollinger Bands (100): | (2.2 - 2.76) | Sell |
C4 Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for C4 Therapeutics, Inc. Stock
Is C4 Therapeutics, Inc. Stock a Buy?
-
C4 Therapeutics, Inc. share price is 2.03 while CCCC 8-day simple moving average is 2.30, which is a Sell signal.
-
The stock price of CCCC is 2.03 while C4 Therapeutics, Inc. 20-day SMA is 2.47, which makes it a Sell.
-
C4 Therapeutics, Inc. 50-day simple moving average is 2.43 while CCCC share price is 2.03, making it a Sell technically.
-
CCCC stock price is 2.03 and C4 Therapeutics, Inc. 200-day simple moving average is 2.08, creating a Sell signal.
CCCC Technical Analysis vs Fundamental Analysis
Sell
19
C4 Therapeutics, Inc. (CCCC)
is a Sell
Is C4 Therapeutics, Inc. a Buy or a Sell?
-
C4 Therapeutics, Inc. stock is rated a SellThe current C4 Therapeutics, Inc. [CCCC] share price is $2.03. The Score for CCCC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
C4 Therapeutics, Inc. Stock Info
Market Cap:
196.7M
Price in USD:
2.03
Share Volume:
2.3M
C4 Therapeutics, Inc. 52-Week Range
52-Week High:
4.26
52-Week Low:
1.09
Sell
19
C4 Therapeutics, Inc. (CCCC)
is a Sell
C4 Therapeutics, Inc. Share Price Forecast
-
What is the C4 Therapeutics, Inc. stock price today?The C4 Therapeutics, Inc. stock price is 2.03 USD today.
-
Will CCCC stock go up or go down?C4 Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is C4 Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, C4 Therapeutics, Inc. is overvalued.
Is C4 Therapeutics, Inc. Stock a Buy?
-
C4 Therapeutics, Inc. share price is 2.03 while CCCC 8-day exponential moving average is 2.23, which is a Sell signal.
-
The stock price of CCCC is 2.03 while C4 Therapeutics, Inc. 20-day EMA is 2.38, which makes it a Sell.
-
C4 Therapeutics, Inc. 50-day exponential moving average is 2.40 while CCCC share price is 2.03, making it a Sell technically.
-
CCCC stock price is 2.03 and C4 Therapeutics, Inc. 200-day simple moving average is 1.58, creating a Buy signal.
Fundamental Analysis of C4 Therapeutics, Inc.
Is C4 Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.23 per share.
Technical Analysis of C4 Therapeutics, Inc.
Should I short C4 Therapeutics, Inc. stock?
-
CCCC Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting C4 Therapeutics, Inc. is a Sell
-
C4 Therapeutics, Inc. Relative Strength Index (RSI) is 34.58, which suggest C4 Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for C4 Therapeutics, Inc. is (2.27 - 2.67), which suggest C4 Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for C4 Therapeutics, Inc. is (2.2 - 2.76), which suggest C4 Therapeutics, Inc. is a Sell
* C4 Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.